Decursin Alleviates Mechanical Allodynia in a Paclitaxel-Induced Neuropathic Pain Mouse Model
Open Access
- 4 March 2021
- Vol. 10 (3), 547
- https://doi.org/10.3390/cells10030547
Abstract
Chemotherapy-induced neuropathic pain (CINP) is a severe adverse effect of platinum- and taxane-derived anticancer drugs. The pathophysiology of CINP includes damage to neuronal networks and dysregulation of signal transduction due to abnormal Ca2+ levels. Therefore, methods that aid the recovery of neuronal networks could represent a potential treatment for CINP. We developed a mouse model of paclitaxel-induced peripheral neuropathy, representing CINP, to examine whether intrathecal injection of decursin could be effective in treating CINP. We found that decursin reduced capsaicin-induced intracellular Ca2+ levels in F11 cells and stimulated neurite outgrowth in a concentration-dependent manner. Decursin directly reduced mechanical allodynia, and this improvement was even greater with a higher frequency of injections. Subsequently, we investigated whether decursin interacts with the transient receptor potential vanilloid 1 (TRPV1). The web server SwissTargetPrediction predicted that TRPV1 is one of the target proteins that may enable the effective treatment of CINP. Furthermore, we discovered that decursin acts as a TRPV1 antagonist. Therefore, we demonstrated that decursin may be an important compound for the treatment of paclitaxel-induced neuropathic pain that functions via TRPV1 inhibition and recovery of damaged neuronal networks.Funding Information
- National Research Foundation of Korea (2019R1C1C1010822)
- the Cooperative Research Program for Agriculture Science & Technology Development conducted by the Rural Development Administration, Republic of Korea (Project No. 01327701)
This publication has 31 references indexed in Scilit:
- Single Oral Dose Pharmacokinetics of Decursin, Decursinol Angelate, and Decursinol in RatsPlanta Medica, 2013
- Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat PainPharmacological Reviews, 2012
- Biopharmaceutical characterization of decursin and their derivatives for drug discoveryDrug Development and Industrial Pharmacy, 2012
- Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK‐3β and CREB through PI3‐K/Akt pathwaysEuropean Journal of Neuroscience, 2012
- Quantitative Determination of Decursin, Decursinol Angelate, and Decursinol in Mouse Plasma and Tumor Tissue Using Liquid-Liquid Extraction and HPLCPlanta Medica, 2011
- Prevention of Paclitaxel-Induced Allodynia by Minocycline: Effect on Loss of Peripheral Nerve Fibers and Infiltration of Macrophages in RatsMolecular Pain, 2010
- Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the ratNeuroscience Letters, 2006
- Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-ResiniferatoxinThe Journal of pharmacology and experimental therapeutics, 2002
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Intrathecal morphine in mice: A new techniqueEuropean Journal of Pharmacology, 1980